Skip to main content
Equibles

NORTHERN TRUST CORP

Bank

Position in DYAI — Dyadic International Inc

CIK 73124 CHICAGO, IL
Back to DYAI Full portfolio

Position in DYAI

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$62,770
+$35,833 QoQ
Shares Held
69,745
+112.3% QoQ
Ownership
0.191%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#13
of 39 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in DYAI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

NORTHERN TRUST CORP holds $7,872,952,300 across 424 Biotechnology names. DYAI ranks #373 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,486,478 $1,235,108,212
2 REGN
Regeneron Pharmaceuticals, Inc.
 916,467 $571,453,829
3 ALNY
Alnylam Pharmaceuticals, Inc.
 886,900 $266,983,504
4 RPRX
Royalty Pharma plc
 4,718,859 $264,586,419
5 RVMD
Revolution Medicines, Inc.
 1,117,110 $209,212,357
6 MRNA
Moderna, Inc.
 2,985,329 $209,062,587
7 INCY
Incyte Corp
 1,761,966 $199,736,460
8 CYTK
Cytokinetics Inc
 1,647,345 $140,337,319

All Filings in DYAI

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $62,770 69,745
2026-03-31 $26,937 32,851
2025-12-31 $63,857 67,933
2025-09-30 $80,160 67,933
2025-06-30 $70,434 71,146
2025-03-31 $97,135 71,952
2024-12-31 $127,618 72,925
2024-09-30 $75,841 72,925
2024-06-30 $108,463 73,286
2024-03-31 $129,583 77,595
2023-12-31 $124,154 77,115
2023-09-30 $145,667 75,869
2023-06-30 $147,191 76,265
2023-03-31 $133,649 75,084
2022-12-31 $93,251 75,815
2022-09-30 $130,708 68,434
2022-06-30 $203,059 66,577
2022-03-31 $199,065 66,135
2021-12-31 $303,666 67,183
2021-09-30 $376,444 67,706
2021-06-30 $281,164 78,319
2021-03-31 $1,331,993 242,622
2020-12-31 $1,559,913 289,947
2020-09-30 $2,282,270 301,489
2020-06-30 $2,677,142 309,139
2020-03-31 $333,288 64,094